Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

107.52
Delayed Data
As of Jul 22
 +0.07 / +0.07%
Today’s Change
92.98
Today|||52-Week Range
140.72
-10.22%
Year-to-Date
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content
Celgene (CELG) Stock Is the 'Chart of the Day'
Jul 22 / TheStreet.com - Paid Partner Content
3 Perfect Stocks for People in Their 40s to Consider Buying
Jul 20 / MotleyFool.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy and Hold
Jul 19 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
Jul 19 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Celgene to partner Jounce in battle against cancerous cells
Jul 19 / FT.com - Paid Partner Content

Today’s Trading

Previous close107.45
Today’s open107.98
Day’s range106.75 - 108.40
Volume3,480,242
Average volume (3 months)4,587,983
Market cap$83.3B
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.91%
Earnings growth (next 5 years)+23.20%
Revenue growth (last year)+16.47%
P/E ratio52.3
Price/Sales11.10
Price/Book14.29

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.60+1.97%
LLYEli Lilly and Co+1.19+1.48%
AGNAllergan+1.14+0.46%
ABTAbbott Laboratories+0.13+0.30%
Data as of 8:13am ET, 07/25/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.39
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

Search for Jobs